A pilot study on the use of the proMACE‐cytaBOM regimen as a first‐line treatment of advanced follicular non‐Hodgkin's lymphoma

The role of intensive conventional dose chemotherapy in advanced low grade non‐Hodgkin's lymphomas is a matter of debate. The Gruppo Italiano per lo Studio dei Linfomi conducted a study to evaluate the efficacy and toxicity of a third‐generation polychemotherapeutic regimen, ProMACE‐CytaBOM, as a first‐line therapy in a selected group of patients with advanced follicular non‐Hodgkin's lymphoma (Fo‐NHL) who were younger than 60 years.

[1]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[2]  A. López-Guillermo,et al.  Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  G. Salles,et al.  Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome. , 1994, Blood.

[4]  T. Lister,et al.  Management of follicular lymphoma , 1991, Current opinion in oncology.

[5]  S. J. Horning.  Low-grade lymphoma 1993: state of the art. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  P. Mclaughlin,et al.  Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  E. Kimby,et al.  Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  S. Horning.  Natural history of and therapy for the indolent non-Hodgkin's lymphomas. , 1993, Seminars in oncology.

[9]  Emili Montserrat,et al.  A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[10]  B. Nathwani,et al.  Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Longo,et al.  What's the deal with follicular lymphomas? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Prof. Dr. Dr. h.c. mult. Karl Lennert,et al.  Histopathology of Non-Hodgkin’s Lymphomas , 1992, Springer Berlin Heidelberg.

[13]  J. Sculier,et al.  Blood coagulation abnormalities during adoptive immunotherapy with interleukin-2 (r-Met Hu IL-2 [ala 125]). , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  E. Jaffe,et al.  Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  E. Jaffe,et al.  The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. , 1988, Seminars in hematology.

[16]  J. Bertino,et al.  High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma. , 1987, Cancer treatment reports.

[17]  T. Lister,et al.  Follicular non-Hodgkin's lymphoma. , 1987, Bailliere's clinical haematology.

[18]  B. Nathwani,et al.  What should be the morphologic criteria for the subdivision of follicular lymphomas , 1986 .

[19]  J. Glick,et al.  Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  C C Whitcomb,et al.  Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[22]  S. Horning,et al.  The natural history of initially untreated low-grade non-Hodgkin's lymphomas. , 1984, The New England journal of medicine.

[23]  E. Jaffe,et al.  Prolonged initial remission in patients with nodular mixed lymphoma. , 1984, Annals of internal medicine.

[24]  J. Glick,et al.  Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. , 1981, Blood.

[25]  S. Rosenberg,et al.  The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation. , 1981, Blood.

[26]  Portlock Cs.  Management of the indolent non-Hodgkin's lymphomas. , 1980 .

[27]  S. Rosenberg,et al.  No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types. , 1979, Annals of internal medicine.

[28]  T. Lister,et al.  Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. , 1978, British medical journal.

[29]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .